Children between 6 and 17 now have a second option to be vaccinated against COVID-19 after the CDC joined the FDA in authorizing Moderna's vaccine, according to a June 24 press release.
The decision comes one day after an advisory panel voted 15-0 to recommend clearing another step for a potential second option for the youth population. A week before, an FDA panel voted 22-0 June 14 recommending Moderna's vaccine for children as young as 6.
Both Pfizer and Moderna's vaccines are authorized nationally for Americans as young as 6 months old.